nabumetone and nadp
nabumetone has been researched along with nadp in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Hofmann, U; Klein, K; Mürdter, T; Schwab, M; Turpeinen, M; Zanger, UM | 1 |
| Nobilis, M; Skarydova, L; Wsól, V | 1 |
Other Studies
2 other study(ies) available for nabumetone and nadp
| Article | Year |
|---|---|
A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomes.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Blocking; Biotransformation; Blotting, Western; Butanones; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 Enzyme System; DNA, Complementary; Enzyme Inhibitors; Humans; In Vitro Techniques; Microsomes, Liver; Nabumetone; NADP; Naphthaleneacetic Acids; Recombinant Proteins; Spectrophotometry, Ultraviolet | 2009 |
Role of carbonyl reducing enzymes in the phase I biotransformation of the non-steroidal anti-inflammatory drug nabumetone in vitro.
Topics: Alcohol Oxidoreductases; Anti-Inflammatory Agents, Non-Steroidal; Biocatalysis; Biotransformation; Butanones; Humans; Kinetics; Liver; Metabolic Detoxication, Phase I; Nabumetone; NADP; Stereoisomerism; Subcellular Fractions | 2013 |